Physician profile
Benjamin D Overley
NPI 1164450946
$643,310.87
in general payments reported to CMS, 2019-2025
21 companies · $124K in 2025
The $124K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $63K · 2021: $100K · 2022: $72K · 2023: $99K · 2024: $112K · 2025: $124K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $324K · Consulting Fee: $6,500 · Travel and Lodging: $3,742 · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $324,288.62 |
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $3,741.83 |
| Food and Beverage | $1,195.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $492,799.81 | 2019-2025 | Trueshot, Colink Mini, Colink 2 |
| Trilliant Surgical LLC. | $114,676.89 | 2019-2025 | 10 Hole Gridlock Helical Plate, Right, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Wright Medical Technology, INC. | $12,053.55 | 2019 | |
| Integra Lifesciences Corporation | $11,326.96 | 2019-2021 | |
| Encore Medical, Lp | $4,575.09 | 2021-2022 | |
| Stryker Corporation | $3,658.68 | 2021-2022 | |
| Mimedx Group, INC. | $1,721.40 | 2025 | |
| In2bones USA, LLC | $1,643.69 | 2022 | |
| Medline Industries Lp | $197.54 | 2023-2024 | |
| Treace Medical Concepts, INC. | $162.33 | 2025 | |
| Paragon 28, INC. | $147.19 | 2022 | |
| Smith+Nephew, INC. | $136.44 | 2020-2025 | Grafix Pl |
| Peerless Surgical INC. | $55.97 | 2025 | |
| Bsn Medical INC | $25.39 | 2025 | |
| Sanara Medtech INC. | $24.49 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $23.16 | 2023 | Puraply |
| Abbvie INC. | $19.64 | 2022 | |
| Horizon Therapeutics Plc | $19.53 | 2023 | Krystexxa |
| Boston Scientific Corporation | $18.15 | 2024 | Wavewriter Alpha Prime 16 |
| Kowa Pharmaceuticals America, INC. | $16.10 | 2022 | |
| Globus Medical, INC. | $8.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Overley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.